Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the ...
A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate ...
A groundbreaking blood test could enable doctors to identify failing prostate cancer treatment earlier, a trial found. Experts believe this discovery could lead to personalised therapies and extend ...
Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently read X-ray images and detect bone fractures, or assess cancer tumors in both ...
Experts are urging officials to rethink their decision on prostate cancer screening, after an MRI approach was shown to slash ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...
For aging men, worrying about prostate health can start to feel like a real … well, you know. But as Dr. Leonard Appleman of ...
Additional Data from ENZAMET Study Show How Decipher Can Help Metastatic Prostate Cancer Patients Avoid Unnecessary Treatment and Enable More Personalized Care The OPTIMA study is a prospective, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results